thats what i am banking on. Good news at that time should get a ton of interest. i dont see how it wouldnt explode at that time. the most recent stuff about the prostate cancer patients sounds very good. i guess that it is not statistaclly significant as in they cant jump to any conclusions but it is very interesting all the same...
what they said:
"Intriguingly, none of the patients in this study belonging to the intermediate or high risk groups as determined by Gleason score developed metastasis, even though metastases would have been predicted to occur in roughly 27% of nine intermediate-risk patients and 60% of eight high-risk patients based upon historical data from patients with these stages of disease. In addition, the median overall survival of six patients with metastatic disease was 89 months, which considerably exceeds that usually observed in this group historically.
"While clearly not designed as an efficacy study, the lack of disease progression observed in this Phase I trial is encouraging," commented Dr. Eric von Hofe, Ph.D., President of Antigen Express. "The longevity of the immunological response speaks to the robust yet specific mechanism of action of AE37 and the technology platform upon which it was designed," he added."
